Key result
Exogenous NGF preserves sympathetic coronary constriction after brief LAD occlusion compared to vehicle.
Why the study?
Does exogenous or endogenous nerve growth factor protect against ischemia-induced dysfunction of cardiac sympathetic nerves in a canine model?
Population
Anesthetized dogs undergoing 7- or 15-minute occlusion of the left anterior descending coronary artery (n=22)
Comparison
Nerve growth factor 10 ng.kg-1.min-1 infused… vs Vehicle infusion during 15-minute or 7-minute…
Design
Preclinical
Follow-up
Immediate post-reperfusion
Authors
Loading...
Exogenously infused and endogenously released nerve growth factor protects against postischemic neural stunning of sympathetic cardiac innervation in a canine model.
Does exogenous or endogenous nerve growth factor protect against ischemia-induced dysfunction of cardiac sympathetic nerves in a canine model?
p-value: p=<.05
Exogenously infused and endogenously released nerve growth factor protects against postischemic neural stunning of sympathetic cardiac innervation in a canine model.
Abe et al. (1997) studied Myocardial ischemia (n=22). Nerve growth factor (NGF) vs. Vehicle was evaluated on Changes in coronary vascular resistance (% delta CVR) to stellate stimulation (p=<.05). Exogenously infused NGF prevented the attenuation of coronary constriction to stellate stimulation after a 15-minute LAD occlusion compared to vehicle (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: